These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 18230350

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
    Trento LK, Pietropolli A, Ticconi C, Gravotta E, De Martino MU, Fabbri A, Piccione E.
    J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Cathepsin K predicts femoral neck bone mineral density change in nonosteoporotic peri- and early postmenopausal women.
    Prezelj J, Ostanek B, Logar DB, Marc J, Hawa G, Kocjan T.
    Menopause; 2008 Feb; 15(2):369-73. PubMed ID: 17882010
    [Abstract] [Full Text] [Related]

  • 29. Lipid profile and bone paradox: higher serum lipids are associated with higher bone mineral density in postmenopausal women.
    Brownbill RA, Ilich JZ.
    J Womens Health (Larchmt); 2006 Apr; 15(3):261-70. PubMed ID: 16620185
    [Abstract] [Full Text] [Related]

  • 30. Bone mineral density and serum levels of aminoterminal propeptides and cross-linked N-telopeptides of type I collagen in elderly men.
    Chandani AK, Scariano JK, Glew RH, Clemens JD, Garry PJ, Baumgartner RN.
    Bone; 2000 May; 26(5):513-8. PubMed ID: 10773592
    [Abstract] [Full Text] [Related]

  • 31. Changes in the serum levels of osteoprotegerin and soluble receptor activator for nuclear factor kappaB ligand after estrogen-progestogen therapy and their relationships with changes in bone mass in postmenopausal women.
    Kim JG, Kim JH, Lee DO, Kim H, Kim JY, Suh CS, Kim SH, Choi YM.
    Menopause; 2008 May; 15(2):357-62. PubMed ID: 17925661
    [Abstract] [Full Text] [Related]

  • 32. Increased formation of 8-iso-prostaglandin F(2alpha) is associated with altered bone metabolism and lower bone mass in hypercholesterolaemic subjects.
    Mangiafico RA, Malaponte G, Pennisi P, Li Volti G, Trovato G, Mangiafico M, Bevelacqua Y, Mazza F, Fiore CE.
    J Intern Med; 2007 Jun; 261(6):587-96. PubMed ID: 17547714
    [Abstract] [Full Text] [Related]

  • 33. Similar efficacy of low and standard doses of transdermal estradiol in controlling bone turnover in postmenopausal women.
    García-Pérez MA, Moreno-Mercer J, Tarín JJ, Cano A.
    Gynecol Endocrinol; 2006 Apr; 22(4):179-84. PubMed ID: 16723303
    [Abstract] [Full Text] [Related]

  • 34. Relationship between serum hsCRP concentration and biochemical bone turnover markers in healthy pre- and postmenopausal women.
    Kim BJ, Yu YM, Kim EN, Chung YE, Koh JM, Kim GS.
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):152-8. PubMed ID: 17466002
    [Abstract] [Full Text] [Related]

  • 35. Relationship between serum levels of vascular endothelial growth factor, hepatocyte growth factor and matrix metalloproteinase-9 with biochemical markers of bone disease in multiple myeloma.
    Alexandrakis MG, Sfiridaki A, Miyakis S, Pappa C, Kandidaki E, Alegakis A, Margioris AN.
    Clin Chim Acta; 2007 Apr; 379(1-2):31-5. PubMed ID: 17234170
    [Abstract] [Full Text] [Related]

  • 36. Relationship between bone turnover and bone density at the proximal femur in stroke patients.
    Paker N, Bugdayci D, Tekdos D, Dere C, Kaya B.
    J Stroke Cerebrovasc Dis; 2009 Apr; 18(2):139-43. PubMed ID: 19251190
    [Abstract] [Full Text] [Related]

  • 37. The usefulness of bone metabolic indices for the prediction of changes in bone mineral density after parathyroidectomy in patients with primary hyperparathyroidism.
    Kaji H, Nomura R, Yamauchi M, Chihara K, Sugimoto T.
    Horm Metab Res; 2006 Jun; 38(6):411-6. PubMed ID: 16823724
    [Abstract] [Full Text] [Related]

  • 38. Relationships between serum leptin level and regional bone mineral density, bone metabolic markers in healthy women.
    Iwamoto I, Douchi T, Kosha S, Murakami M, Fujino T, Nagata Y.
    Acta Obstet Gynecol Scand; 2000 Dec; 79(12):1060-4. PubMed ID: 11130088
    [Abstract] [Full Text] [Related]

  • 39. The relationship between bone turnover markers and BMD decreasing rates in Chinese middle-aged women.
    Zhou XW, Wu XY, Luo L, Guo LJ, Lei MX, Zhang H, Xie H, Peng YQ, Wu XP, Liao EY.
    Clin Chim Acta; 2011 Aug 17; 412(17-18):1648-57. PubMed ID: 21635877
    [Abstract] [Full Text] [Related]

  • 40. Paraoxonase-1 activity as a marker of atherosclerosis is not associated with low bone mineral density in healthy postmenopausal women.
    Verit FF, Celik H, Yazgan P, Erel O, Geyikli I.
    Arch Gynecol Obstet; 2007 May 17; 275(5):353-9. PubMed ID: 17086419
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.